United States · FDA National Drug Code directory
LYTGOBI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64842-0127_87b2e0c4-3351-4a85-b721-19a0574daafa
- Product NDC
- 64842-0127
- Form
- TABLET
- Composition / generic term
- FUTIBATINIB
- Labeler
- TAIHO PHARMACEUTICAL CO., LTD.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260601
- Source listing expiry
- 20261231
Source-listed ingredients
- FUTIBATINIB — 16 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (64842-0127-7) / 7 TABLET in 1 BLISTER PACK · 64842-0127-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →